Evidence map›Paper›PMID 30100742›Full record

ArticleOncoTargets and therapy2018

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer.

Mina Ding, Yue Li, Yang Yang, Kun Zhu, Shuanlong Che, Zhenhua Lin, Liyan Chen

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Computational andFrontiers in cell and developmental biology · 2020
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mina DingDepartment of Biochemistry and Molecular Biology, Yanbian University Medical College, Yanji 133002, China, lychen@ybu.edu.cn.
Yue LiDepartment of Biochemistry and Molecular Biology, Yanbian University Medical College, Yanji 133002, China, lychen@ybu.edu.cn.
Yang YangDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji 133002, China.
Kun ZhuDepartment of Biochemistry and Molecular Biology, Yanbian University Medical College, Yanji 133002, China, lychen@ybu.edu.cn.
Shuanlong CheDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji 133002, China.
Zhenhua LinDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji 133002, China.
Liyan ChenDepartment of Biochemistry and Molecular Biology, Yanbian University Medical College, Yanji 133002, China, lychen@ybu.edu.cn.
Yanbian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveT-cell lymphoma invasion and metastasis inducing factor 1 (Tiam1) is known to be involved in tumor progression. However, its molecular roles and mechanism in pancreatic ductal adenocarcinoma (PDAC) remain unclear. The purpose of this study is to determine Tiam1 expression levels and investigate its underlying molecular mechanism in PDAC. MATERIALS AND

methodsTiam1 protein expression levels in PDAC tissues were examined using immunohistochemistry. Tiam1 expression was confirmed in pancreatic cancer (PC) cells by Western blot and immunofluorescence staining. Tiam1-silenced PC cells were created using short interfering RNA. Subsequently, colony formation, scratch, and migration and invasion assays were carried out to explore the molecular mechanisms of Tiam1 in PC cells.

resultsThe results indicated that Tiam1 expression was significantly higher in PDAC tissues than in paired non-tumor tissues, and overexpression of Tiam1 was significantly correlated with histological grade (

conclusionHigh expression of Tiam1 plays a significant role in the progression of PDAC and may be a potential biomarker of poor prognosis as well as a therapeutic target.

Indexed as

carcinogenesispancreatic cancerprognosissurvival analysisTiam1

Identifiers

PMID30100742
PMCPMC6067591
OpenAlexW2883587784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.